Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2007

Open Access 01-12-2007 | Research

Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery

Authors: Stephen P Povoski, Donn C Young, Michael J Walker, William E Carson, Lisa D Yee, Doreen M Agnese, William B Farrar

Published in: World Journal of Surgical Oncology | Issue 1/2007

Login to get access

Abstract

Background

Although sentinel lymph node (SLN) biopsy is a standard of care for the evaluation of the axillary lymph nodes during breast cancer surgery, a substantial degree of variation exists among individual surgeons as to what represents an adequate assessment. The aim of the current study was to assess when metastatic disease was first identified within consecutively harvested SLN candidates for invasive breast cancers demonstrating a positive SLN.

Methods

We retrospectively analyzed a series of 400 breast cancers from a recently published prospective randomized clinical trial. A combined radiocolloid and blue dye technique was used. All potential SLN candidates, containing counts of at least 10% of the hottest SLN and/or containing blue dye, were harvested and were consecutively numbered in the order of the decreasing level of counts (with the hottest SLN representing SLN #1).

Results

Among 371 invasive breast cancers, a SLN was identified within 353 cases (95%). Mean number of SLNs identified was 2.5 (range, 1 to 9), with a single SLN identified in 104 (29%) cases, two identified in 110 (31%), three identified in 73 (21%), four identified in 35 (10%), five identified in 16 (5%), and six or more identified in 15 (4%). A positive SLN was found in 104 (29%) cases. SLN #1 was the first positive SLN in 86 (83%). SLN #2 was the first positive SLN in 15 (14%). SLN #3, SLN #4, and SLN #5 were the first positive SLN in one case (1%) each. A positive SLN was found in 18% (19/104) of cases when a single SLN was identified, as compared to in 34% (85/249) when two or more SLNs were identified (P = 0.003).

Conclusion

The accurate and optimal assessment of the axilla during breast cancer surgery requires persistence and diligence for attempting to identify all potential SLN candidates in order to avoid failing to recognize a positive SLN. The scenario in which only a single negative SLN candidate is intraoperatively identified is one that should raise some concern to the operating surgeon.
Literature
1.
go back to reference Burak WE, Agnese DM, Povoski SP: Advances in the surgical management of early stage invasive breast cancer. Curr Probl Surg. 2004, 41: 877-936. 10.1067/S0011-3840(04)00113-3.CrossRef Burak WE, Agnese DM, Povoski SP: Advances in the surgical management of early stage invasive breast cancer. Curr Probl Surg. 2004, 41: 877-936. 10.1067/S0011-3840(04)00113-3.CrossRef
2.
go back to reference Povoski SP, Olsen JO, Young DC, Clarke J, Burak WE, Walker MJ, Carson WE, Yee LD, Agnese DM, Pozderac RV, Hall NC, Farrar WB: Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann Surg Oncol. 2006, 13: 1412-1421. 10.1245/s10434-006-9022-z.CrossRefPubMed Povoski SP, Olsen JO, Young DC, Clarke J, Burak WE, Walker MJ, Carson WE, Yee LD, Agnese DM, Pozderac RV, Hall NC, Farrar WB: Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann Surg Oncol. 2006, 13: 1412-1421. 10.1245/s10434-006-9022-z.CrossRefPubMed
3.
go back to reference Martin RC, Edwards MJ, Wong SL, Tuttle TM, Carlson DJ, Brown CM, Noyes RD, Glaser RL, Vennekotter DJ, Turk PS, Tate PS, Sardi A, Cerrito PB, McMasters KM, University of Louisville Breast Cancer Sentinel Lymph Node Study: Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. Surgery. 2000, 128: 139-144. 10.1067/msy.2000.108064.CrossRefPubMed Martin RC, Edwards MJ, Wong SL, Tuttle TM, Carlson DJ, Brown CM, Noyes RD, Glaser RL, Vennekotter DJ, Turk PS, Tate PS, Sardi A, Cerrito PB, McMasters KM, University of Louisville Breast Cancer Sentinel Lymph Node Study: Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. Surgery. 2000, 128: 139-144. 10.1067/msy.2000.108064.CrossRefPubMed
4.
go back to reference Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ, Cerrito PB, McMasters KM: Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg. 2001, 192: 684-689. 10.1016/S1072-7515(01)00858-4. discussion 689–691CrossRefPubMed Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ, Cerrito PB, McMasters KM: Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg. 2001, 192: 684-689. 10.1016/S1072-7515(01)00858-4. discussion 689–691CrossRefPubMed
5.
go back to reference McCarter MD, Yeung H, Fey J, Borgen PI, Cody HS: The breast cancer patient with multiple sentinel nodes: when to stop?. J Am Coll Surg. 2001, 192: 692-697. 10.1016/S1072-7515(01)00847-X.CrossRefPubMed McCarter MD, Yeung H, Fey J, Borgen PI, Cody HS: The breast cancer patient with multiple sentinel nodes: when to stop?. J Am Coll Surg. 2001, 192: 692-697. 10.1016/S1072-7515(01)00847-X.CrossRefPubMed
6.
go back to reference Martin RC, Fey J, Yeung H, Borgen PI, Cody HS: Highest isotope count does not predict sentinel node positivity in all breast cancer patients. Ann Surg Oncol. 2001, 8: 592-597. 10.1007/s10434-001-0592-5.CrossRefPubMed Martin RC, Fey J, Yeung H, Borgen PI, Cody HS: Highest isotope count does not predict sentinel node positivity in all breast cancer patients. Ann Surg Oncol. 2001, 8: 592-597. 10.1007/s10434-001-0592-5.CrossRefPubMed
7.
go back to reference Zervos EE, Badgwell BD, Abdessalam SF, Farrar WB, Walker MJ, Yee LD, Burak WE: Selective analysis of the sentinel node in breast cancer. Am J Surg. 2001, 182: 372-376. 10.1016/S0002-9610(01)00740-1.CrossRefPubMed Zervos EE, Badgwell BD, Abdessalam SF, Farrar WB, Walker MJ, Yee LD, Burak WE: Selective analysis of the sentinel node in breast cancer. Am J Surg. 2001, 182: 372-376. 10.1016/S0002-9610(01)00740-1.CrossRefPubMed
8.
go back to reference Schrenk P, Rehberger W, Shamiyeh A, Wayand W: Sentinel node biopsy for breast cancer: does the number of sentinel nodes removed have an impact on the accuracy of finding a positive node?. J Surg Oncol. 2002, 80: 130-136. 10.1002/jso.10112.CrossRefPubMed Schrenk P, Rehberger W, Shamiyeh A, Wayand W: Sentinel node biopsy for breast cancer: does the number of sentinel nodes removed have an impact on the accuracy of finding a positive node?. J Surg Oncol. 2002, 80: 130-136. 10.1002/jso.10112.CrossRefPubMed
9.
go back to reference Bourgeois P, Nogaret JM, Veys I, Hertens D, Dagnelie J, Vanhaudenaerde C, Verdebout JM, Larsimont D: How 'hot' is the pathologically positive sentinel lymph node in breast cancer patients?. Nucl Med Commun. 2003, 24: 513-518. 10.1097/00006231-200305000-00005.CrossRefPubMed Bourgeois P, Nogaret JM, Veys I, Hertens D, Dagnelie J, Vanhaudenaerde C, Verdebout JM, Larsimont D: How 'hot' is the pathologically positive sentinel lymph node in breast cancer patients?. Nucl Med Commun. 2003, 24: 513-518. 10.1097/00006231-200305000-00005.CrossRefPubMed
10.
go back to reference Kennedy RJ, Kollias J, Gill PG, Bochner M, Coventry BJ, Farshid G: Removal of two sentinel nodes accurately stages the axilla in breast cancer. Br J Surg. 2003, 90: 1349-1353. 10.1002/bjs.4298.CrossRefPubMed Kennedy RJ, Kollias J, Gill PG, Bochner M, Coventry BJ, Farshid G: Removal of two sentinel nodes accurately stages the axilla in breast cancer. Br J Surg. 2003, 90: 1349-1353. 10.1002/bjs.4298.CrossRefPubMed
11.
go back to reference Dabbs DJ, Johnson R: The optimal number of sentinel lymph nodes for focused pathologic examination. Breast J. 2004, 10: 186-189. 10.1111/j.1075-122X.2004.21283.x.CrossRefPubMed Dabbs DJ, Johnson R: The optimal number of sentinel lymph nodes for focused pathologic examination. Breast J. 2004, 10: 186-189. 10.1111/j.1075-122X.2004.21283.x.CrossRefPubMed
12.
go back to reference Martin RC, Chagpar A, Scoggins CR, Edwards MJ, Hagendoorn L, Stromberg AJ, McMasters KM, University of Louisville Breast Cancer Sentinel Lymph Node Study: Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg. 2005, 241: 1005-1012. 10.1097/01.sla.0000165200.32722.02.PubMedCentralCrossRefPubMed Martin RC, Chagpar A, Scoggins CR, Edwards MJ, Hagendoorn L, Stromberg AJ, McMasters KM, University of Louisville Breast Cancer Sentinel Lymph Node Study: Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg. 2005, 241: 1005-1012. 10.1097/01.sla.0000165200.32722.02.PubMedCentralCrossRefPubMed
13.
go back to reference Takei H, Suemasu K, Kurosumi M, Horii Y, Ninomiya J, Kamimura M, Naganuma R, Uchida K, Igarashi K, Inoue K, Tabei T: Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer. Breast Cancer. 2006, 13: 179-185. 10.2325/jbcs.13.179.CrossRefPubMed Takei H, Suemasu K, Kurosumi M, Horii Y, Ninomiya J, Kamimura M, Naganuma R, Uchida K, Igarashi K, Inoue K, Tabei T: Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer. Breast Cancer. 2006, 13: 179-185. 10.2325/jbcs.13.179.CrossRefPubMed
14.
go back to reference Woznick A, Franco M, Bendick P, Benitez PR: Sentinel lymph node dissection for breast cancer: how many nodes are enough and which technique is optimal?. Am J Surg. 2006, 191: 330-333. 10.1016/j.amjsurg.2005.10.031.CrossRefPubMed Woznick A, Franco M, Bendick P, Benitez PR: Sentinel lymph node dissection for breast cancer: how many nodes are enough and which technique is optimal?. Am J Surg. 2006, 191: 330-333. 10.1016/j.amjsurg.2005.10.031.CrossRefPubMed
15.
go back to reference Low KSS, Littlejohn DRG: Optimal number of sentinel nodes after intradermal injection isotope and blue dye. ANZ J Surg. 2006, 76: 472-475. 10.1111/j.1445-2197.2006.03752.x.CrossRefPubMed Low KSS, Littlejohn DRG: Optimal number of sentinel nodes after intradermal injection isotope and blue dye. ANZ J Surg. 2006, 76: 472-475. 10.1111/j.1445-2197.2006.03752.x.CrossRefPubMed
16.
go back to reference Kim T, Giuliano AE, Lyman GH: Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006, 106: 4-16. 10.1002/cncr.21568.CrossRefPubMed Kim T, Giuliano AE, Lyman GH: Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006, 106: 4-16. 10.1002/cncr.21568.CrossRefPubMed
17.
go back to reference McMasters KM, Wong SL, Chao C: Comment on the article "Highest isotope count does not predict sentinel node positivity in all breast cancer patients," by Martin et al., August 2001, Annals of Surgical Oncology. Ann Surg Oncol. 2002, 9: 317-10.1245/aso.2002.9.3.317.PubMed McMasters KM, Wong SL, Chao C: Comment on the article "Highest isotope count does not predict sentinel node positivity in all breast cancer patients," by Martin et al., August 2001, Annals of Surgical Oncology. Ann Surg Oncol. 2002, 9: 317-10.1245/aso.2002.9.3.317.PubMed
Metadata
Title
Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery
Authors
Stephen P Povoski
Donn C Young
Michael J Walker
William E Carson
Lisa D Yee
Doreen M Agnese
William B Farrar
Publication date
01-12-2007
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2007
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-5-18

Other articles of this Issue 1/2007

World Journal of Surgical Oncology 1/2007 Go to the issue